Rapamycin and trametinib are commonly used to treat cancer in humans, but researchers have found that they can also extend life in mice. (Image credit: JoeZellner via Getty Images)
According to a new study, scientists have found that a combination of two anti-cancer drugs can increase the lifespan of mice by about 30%.
Both trametinib and rapamycin were effective in extending the lifespan of mice when given individually, but had even greater effects when given together. They also reduced chronic inflammation and slowed the development of cancer in aging mice.
However, mice are not humans, so the new findings do not necessarily indicate that people will live longer when taking these drugs (outside of their current uses). However, the study authors noted that the drugs, which are approved by the U.S. Food and Drug Administration (FDA), are promising candidates for human clinical trials aimed at studying ways to improve the aging process in older people.
You may like
Sourse: www.livescience.com
